New findings could lead to more effective, less toxic treatments, improving survival and quality of life for young patients.

Brain cancer has an internal clock and syncs its daily rhythms to match—and take advantage of—the rhythms of its host.

Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy.

Researchers have found a substance that effectively combats glioblastomas, at least in the laboratory: an antidepressant called vortioxetine.

"Our hope is that if early detection [of brain cancer] is more feasible, then there is an increased chance of survival."

Researchers say KL-50, a "chameleon" compound, effectively targets brain tumors without harming healthy surrounding tissue.

Scientists have identified a key cell pathway in glioblastoma, potentially opening new avenues for therapy.

A drug-like compound could be a game-changer in the fight against glioblastoma. "We haven't found a single brain cancer cell line that it can't kill."

Glioblastoma is one of the most treatment-resistant cancers. A new study offers clues as to how it can aggressively resist immunotherapy.

A newly-developed nanoparticle offers a more effective way to deliver a chemotherapy drug to fast growing, aggressive brain tumors.